PerspectiveCANCER THERAPY

Beyond PARP—POLθ as an anticancer target

See allHide authors and affiliations

Science  16 Mar 2018:
Vol. 359, Issue 6381, pp. 1217-1218
DOI: 10.1126/science.aar5149

Log in to view full text

Log in through your institution

Log in through your institution

Navigate This Article